On Sept. 8, 2020, the CEOs of AstraZeneca, BioNTech, GlaxoSmithKline, Johnson & Johnson, Merck, Moderna, Novavax, Pfizer, and…
On Sept. 2, 2020, Broad Institute of MIT and Harvard announced it had partnered with 108 public and…
On Aug. 28, 2020, Moderna confirmed that the Company was engaged in discussions with the Ministry of Health,…
On Aug. 26, 2020, researchers announced an inexpensive, sensitive, CRISPR-based tests diagnose two deadly viruses in settings with…
On Aug. 25, 2020, data from the Broad Institute of MIT and Harvard, Massachusetts General Hospital, the Massachusetts…
On Aug. 24, 2020, humans are not the only species facing a potential threat from SARS-CoV-2, the novel…
On Aug. 20, 2020, in the most comprehensive study of COVID-19 pediatric patients to date, Harvard Medical School…
On Aug. 19, 2020, Johnson & Johnson announced an agreement to acquire Momenta Pharmaceuticals, a company that discovers…
On Aug. 11, 2020, Moderna announced that the U.S. government had secured 100 million doses of mRNA-1273. The…
On Aug. 5, 2020, the National Institute of Allergy and Infectious Diseases (NIAID) announced that the investigational vaccine…
On Aug. 4, 2020, Yale University announced it was among the core partners of the new Center for…
On Jul. 28, 2020, Moderna announced a preclinical study evaluating mRNA-1273, its vaccine candidate against COVID-19, was published…
On Jul. 27, 2020, the National Institutes of Health (NIH) announced that a phase 3 clinical trial designed…
On Jul. 27, 2020, Moderna announced that the Phase 3 study of its mRNA vaccine candidate (mRNA-1273) against…
On Jul. 26, 2020, Moderna announced a modification to its contract with the Biomedical Advanced Research and Development…
On Jul. 21, 2020, National Institutes of Health (NIH) researchers reported early results from the first COVID-19 vaccine…
On Jul. 21, 2020, researchers from the National Institutes of Health (NIH) announced that early results from the…
On Jul. 14, 2020, Moderna announced the publication of an interim analysis of the open-label Phase 1 study…
On Jul. 10, 2020, the Imaging Platform at the Broad Institute of MIT and Harvard, together with industry…
On Jul. 9, 2020 Moderna and Laboratorios Farmaceuticos Rovi announced a collaboration for large-scale, commercial fill-finish manufacturing of…
On Jul. 8, 2020, Moderna announced that it had completed enrollment for both cohorts of the Phase 2…
On Jul. 8, 2020, Constant Therapeutics reported that its peptide drug TXA127 was tested in a series of…
On Jul. 7, 2020, Tonix Pharmaceuticals announced its intent to purchase an approximately 40,000 square foot facility in…
On Jun. 30, 2020, AquaBounty Technologies announced it had successfully commenced the commercial-scale harvest of conventional Atlantic salmon…
On Jun. 25, 2020 Moderna announced a collaboration for large-scale, commercial fill-finish manufacturing of Moderna’s mRNA-based COVID-19 vaccine…
On Jun. 11, 2020, Moderna announced progress on late-stage development of mRNA-1273, the Company’s mRNA vaccine candidate against…
On Jun. 4, 2020, data from the Broad Institute of MIT and Harvard, Massachusetts General Hospital, and the…
On May 29, 2020, Moderna announced the first participants in each age cohort had been dosed in the…
On May 28, 2020, Biogen and the Lemelson-MIT Program (LMIT) at the Massachusetts Institute of Technology announced the…
On May 18, 2020, Moderna announced positive interim clinical data of mRNA-1273, its vaccine candidate against novel coronavirus…